CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2)

CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2)

Cell-based therapy offers great promise for treating degenerative diseases. Although autologous cell-based therapy is ideal, it may be impractical due to the high manufacturing cost and long production time. Allogeneic cell-based therapy offers a more cost-effective alternative; however, the risk of...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Nontaphat Thongsin, Siriwal Suwanpitak, Methichit Wattanapanitch
التنسيق:	مقال
اللغة:	English
منشور في:	Elsevier 2023-09-01
سلاسل:	Stem Cell Research
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S1873506123001241

مواد مشابهة

Generation of a homozygous TIGIT gene knockout (TIGIT−/−) human iPSC line (MUSIi001-A-3) using CRISPR/Cas9 system
حسب: Jakkrapatra Srisantitham, وآخرون
منشور في: (2024-12-01)

Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers
حسب: Nontaphat Thongsin, وآخرون
منشور في: (2024-11-01)

A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors.
حسب: Koollawat Chupradit, وآخرون
منشور في: (2022-01-01)

Generation of an induced pluripotent stem cell line (MUSIi015-A) from a diabetic patient carrying mutations in ZYG11A (p.L475P) and GATA6 (p.E51K)
حسب: Siriwal Suwanpitak, وآخرون
منشور في: (2022-08-01)

A three-dimensional immune-oncology model for studying in vitro primary human NK cell cytotoxic activity.
حسب: Nontaphat Thongsin, وآخرون
منشور في: (2022-01-01)

Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system
حسب: Kongtana Trakarnsanga, وآخرون
منشور في: (2022-09-01)

Generation of two induced pluripotent stem cell lines (MUSIi011-A and MUSIi011-B) from peripheral blood T lymphocytes of a healthy individual
حسب: Ratchapong Netsrithong, وآخرون
منشور في: (2019-08-01)

Generation of a human induced pluripotent stem cell line (MUSIi001-A) from caesarean section scar fibroblasts using Sendai viral vectors
حسب: Methichit Wattanapanitch, وآخرون
منشور في: (2018-03-01)

Establishment of an integration-free induced pluripotent stem cell line (MUSIi005-A) from exfoliated renal epithelial cells
حسب: Bootsakorn Boonkaew, وآخرون
منشور في: (2018-07-01)

Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells
حسب: Ratchapong Netsrithong, وآخرون
منشور في: (2020-11-01)

Generation of RUNX1c-eGFP induced pluripotent stem cell, MUSIi012-A-4, using CRISPR/Cas9
حسب: Pimonwan Srisook, وآخرون
منشور في: (2023-03-01)

Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
حسب: Methichit Wattanapanitch
منشور في: (2019-01-01)

Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp fibroblasts of a male patient with androgenetic alopecia
حسب: Nutnicha Tantarungsee, وآخرون
منشور في: (2019-07-01)

A live single-cell reporter system reveals drug-induced plasticity of a cancer stem cell-like population in cholangiocarcinoma
حسب: Krittiyabhorn Kongtanawanich, وآخرون
منشور في: (2024-09-01)

Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system
حسب: Elena Romano, وآخرون
منشور في: (2021-12-01)

An induced pluripotent stem cell line (MUSIi019-A) generated from a patient with distal renal tubular acidosis carrying a compound heterozygous mutation in solute carrier family 4 member 1 (SLC4A1) gene
حسب: Narissara Kaewboonlert, وآخرون
منشور في: (2023-03-01)

CIITA promoter polymorphism impairs monocytes HLA-DR expression in patients with septic shock
حسب: Jordi Miatello, وآخرون
منشور في: (2022-11-01)

Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing
حسب: Johanna Heider, وآخرون
منشور في: (2022-10-01)

One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system
حسب: Methichit Wattanapanitch, وآخرون
منشور في: (2018-02-01)

CRISPR/Cas9-mediated targeted chromosome elimination
حسب: Erwei Zuo, وآخرون
منشور في: (2017-11-01)

Episomal vector-based generation of human induced pluripotent stem cell line MUSIi020-A from peripheral blood T-cells
حسب: Ponthip Pratumkaew, وآخرون
منشور في: (2022-10-01)

Generation of induced pluripotent stem cell line carrying frameshift variants in NPHP1 (UCSFi001-A-68) using CRISPR/Cas9
حسب: Emma Dyke, وآخرون
منشور في: (2023-04-01)

Generation of induced pluripotent stem cell lines carrying monoallelic (UCSFi001-A-60) or biallelic (UCSFi001-A-61; UCSFi001-A-62) frameshift variants in CACNA1A using CRISPR/Cas9
حسب: Marina P. Hommersom, وآخرون
منشور في: (2022-05-01)

CRISPR/Cas9-based GLA knockout to generate the female Fabry disease human induced pluripotent stem cell line MHHi001-A-15
حسب: Malte Juchem, وآخرون
منشور في: (2024-09-01)

Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9
حسب: Caterina Gargano, وآخرون
منشور في: (2023-12-01)

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
حسب: Chenhe Su, وآخرون
منشور في: (2021-08-01)

CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches
حسب: Elise Ramia, وآخرون
منشور في: (2019-03-01)

Generation of miR-15a/16-1 cluster-deficient human induced pluripotent stem cell line (DMBi001-A-2) using CRISPR/Cas9 gene editing
حسب: Jacek Stępniewski, وآخرون
منشور في: (2023-04-01)

Establishment of heterozygous and homozygous SHANK3 knockout clonal pluripotent stem cells from the parental hESC line SA001 using CRISPR/Cas9
حسب: Laure Chatrousse, وآخرون
منشور في: (2023-10-01)

Elimination of GGTA1, CMAH, β4GalNT2 and CIITA genes in pigs compromises human versus pig xenogeneic immune reactions
حسب: Jing Xu, وآخرون
منشور في: (2024-08-01)

Elimination of bla KPC−2-mediated carbapenem resistance in Escherichia coli by CRISPR-Cas9 system
حسب: Shuan Tao, وآخرون
منشور في: (2023-10-01)

CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
حسب: Hassen S Wollebo, وآخرون
منشور في: (2015-01-01)

CRISPR-Cas gene perturbation and editing in human induced pluripotent stem cells
حسب: van Essen, M, وآخرون
منشور في: (2021)

Generation of a PDGFRB-mCherry knock-in reporter human induced pluripotent stem cell line (KITi001-A-1), using CRISPR/Cas9 nuclease
حسب: Seongyea Jo, وآخرون
منشور في: (2023-06-01)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
حسب: Huan Liu, وآخرون
منشور في: (2022-06-01)

CIITA and its dual roles in MHC gene transcription
حسب: Dinah S. Singer, وآخرون
منشور في: (2013-12-01)

MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer.
حسب: Lydie M O Barbeau, وآخرون
منشور في: (2025-01-01)

Generation of induced pluripotent stem cell line (UCSFi001-A-77) carrying a biallelic frameshift variant in exon 4 of SGIP1 through CRISPR/Cas9
حسب: Neelam Fatima, وآخرون
منشور في: (2024-10-01)

Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking
حسب: Ruthellen H. Anderson, وآخرون
منشور في: (2018-12-01)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
حسب: Vineet Anand, وآخرون
منشور في: (2022-09-01)